Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.

TitleReporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.
Publication TypeJournal Article
Year of Publication2013
AuthorsGreen, RC, Lupski, JR, Biesecker, LG
JournalJAMA
Volume310
Issue4
Pagination365-6
Date Published2013 Jul 24
ISSN1538-3598
KeywordsDisclosure, Genetic Predisposition to Disease, Genetic Testing, Humans, Incidental Findings, Mandatory Reporting, Mutation, Personal Autonomy, Risk, Sequence Analysis, DNA
DOI10.1001/jama.2013.41703
Alternate JournalJAMA
PubMed ID23917280
PubMed Central IDPMC3963427
Grant ListCA154517 / CA / NCI NIH HHS / United States
U54 HG006542 / HG / NHGRI NIH HHS / United States
R01 HG003178 / HG / NHGRI NIH HHS / United States
R01 HG006615 / HG / NHGRI NIH HHS / United States
UM1 HG006542 / HG / NHGRI NIH HHS / United States
U54 HG003273 / HG / NHGRI NIH HHS / United States
HG02213 / HG / NHGRI NIH HHS / United States
HG003178 / HG / NHGRI NIH HHS / United States
HG005092 / HG / NHGRI NIH HHS / United States
HG006542 / HG / NHGRI NIH HHS / United States
/ / Intramural NIH HHS / United States
R01 CA154517 / CA / NCI NIH HHS / United States
R01 HG002213 / HG / NHGRI NIH HHS / United States
HG006615 / HG / NHGRI NIH HHS / United States
R01 HG005092 / HG / NHGRI NIH HHS / United States
R01 NS058529 / NS / NINDS NIH HHS / United States
NS058529 / NS / NINDS NIH HHS / United States

Similar Publications

Hong YSoo, Battle SL, Shi W, Puiu D, Pillalamarri V, Xie J, et al.. Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality. Nat Commun. 2023;14(1):6113.
Petit F, Longoni M, Wells J, Maser RS, Bogenschutz EL, Dysart MJ, et al.. PLS3 missense variants affecting the actin-binding domains cause X-linked congenital diaphragmatic hernia and body-wall defects. Am J Hum Genet. 2023;110(10):1787-1803.
Mistretta B, Rankothgedera S, Castillo M, Rao M, Holloway K, Bhardwaj A, et al.. Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023;14:1188831.